Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Edwards Lifesciences Corp. (NYSE:EW)

Analysis of Solvency Ratios

Beginner level

Solvency Ratios (Summary)

Edwards Lifesciences Corp., solvency ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Debt Ratios
Debt to equity 0.13 0.14 0.19 0.35 0.31
Debt to equity (including operating lease liability) 0.15 0.16 0.19 0.35 0.31
Debt to capital 0.12 0.13 0.16 0.26 0.24
Debt to capital (including operating lease liability) 0.13 0.14 0.16 0.26 0.24
Debt to assets 0.08 0.09 0.11 0.18 0.18
Debt to assets (including operating lease liability) 0.10 0.10 0.11 0.18 0.18
Financial leverage 1.58 1.56 1.70 1.93 1.72
Coverage Ratios
Interest coverage 59.02 57.35 26.46 45.61 39.43
Fixed charge coverage 20.80 25.00 14.38 21.49 18.53

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Edwards Lifesciences Corp.’s debt to equity ratio improved from 2018 to 2019 and from 2019 to 2020.
Debt to equity ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. Edwards Lifesciences Corp.’s debt to equity ratio (including operating lease liability) improved from 2018 to 2019 and from 2019 to 2020.
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Edwards Lifesciences Corp.’s debt to capital ratio improved from 2018 to 2019 and from 2019 to 2020.
Debt to capital ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. Edwards Lifesciences Corp.’s debt to capital ratio (including operating lease liability) improved from 2018 to 2019 and from 2019 to 2020.
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Edwards Lifesciences Corp.’s debt to assets ratio improved from 2018 to 2019 and from 2019 to 2020.
Debt to assets ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. Edwards Lifesciences Corp.’s debt to assets ratio (including operating lease liability) improved from 2018 to 2019 and from 2019 to 2020.
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Edwards Lifesciences Corp.’s financial leverage ratio decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Edwards Lifesciences Corp.’s interest coverage ratio improved from 2018 to 2019 and from 2019 to 2020.
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Edwards Lifesciences Corp.’s fixed charge coverage ratio improved from 2018 to 2019 but then slightly deteriorated from 2019 to 2020.

Debt to Equity

Edwards Lifesciences Corp., debt to equity calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Short-term debt —  —  —  598,000  — 
Long-term debt 595,000  594,400  593,800  438,400  822,300 
Total debt 595,000  594,400  593,800  1,036,400  822,300 
 
Stockholders’ equity 4,574,300  4,148,300  3,140,400  2,956,200  2,619,000 
Solvency Ratio
Debt to equity1 0.13 0.14 0.19 0.35 0.31
Benchmarks
Debt to Equity, Competitors2
Becton, Dickinson & Co. 0.75 0.92 1.02 1.46 1.51
Boston Scientific Corp. 0.60 0.72 0.81 0.80 0.81
Danaher Corp. 0.53 0.72 0.35 0.40 0.53
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00
Medtronic PLC 0.49 0.51 0.51 0.66 0.60
Stryker Corp. 1.07 0.87 0.84 0.72 0.72
Thermo Fisher Scientific Inc. 0.63 0.60 0.69 0.83 0.77
UnitedHealth Group Inc. 0.66 0.71 0.71 0.66 0.86
Debt to Equity, Sector
Health Care Equipment & Services 0.59 0.64 0.62 0.69 0.71
Debt to Equity, Industry
Health Care 0.92 0.91 0.83 0.84 0.79

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Debt to equity = Total debt ÷ Stockholders’ equity
= 595,000 ÷ 4,574,300 = 0.13

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio A solvency ratio calculated as total debt divided by total shareholders’ equity. Edwards Lifesciences Corp.’s debt to equity ratio improved from 2018 to 2019 and from 2019 to 2020.

Debt to Equity (including Operating Lease Liability)

Edwards Lifesciences Corp., debt to equity (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Short-term debt —  —  —  598,000  — 
Long-term debt 595,000  594,400  593,800  438,400  822,300 
Total debt 595,000  594,400  593,800  1,036,400  822,300 
Operating lease liabilities, current portion 27,200  25,500  —  —  — 
Operating lease liabilities, long-term portion 72,700  58,900  —  —  — 
Total debt (including operating lease liability) 694,900  678,800  593,800  1,036,400  822,300 
 
Stockholders’ equity 4,574,300  4,148,300  3,140,400  2,956,200  2,619,000 
Solvency Ratio
Debt to equity (including operating lease liability)1 0.15 0.16 0.19 0.35 0.31
Benchmarks
Debt to Equity (including Operating Lease Liability), Competitors2
Becton, Dickinson & Co. 0.77 0.92 1.02 1.46 1.51
Boston Scientific Corp. 0.63 0.75 0.81 0.80 0.81
Danaher Corp. 0.56 0.74 0.35 0.40 0.53
Intuitive Surgical Inc. 0.01 0.01 0.00 0.00 0.00
Medtronic PLC 0.51 0.51 0.51 0.66 0.60
Stryker Corp. 1.10 0.90 0.84 0.72 0.72
Thermo Fisher Scientific Inc. 0.65 0.62 0.69 0.83 0.77
UnitedHealth Group Inc. 0.73 0.77 0.71 0.66 0.86
Debt to Equity (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.63 0.67 0.62 0.69 0.71
Debt to Equity (including Operating Lease Liability), Industry
Health Care 0.95 0.94 0.83 0.84 0.79

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Stockholders’ equity
= 694,900 ÷ 4,574,300 = 0.15

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to equity ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total shareholders’ equity. Edwards Lifesciences Corp.’s debt to equity ratio (including operating lease liability) improved from 2018 to 2019 and from 2019 to 2020.

Debt to Capital

Edwards Lifesciences Corp., debt to capital calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Short-term debt —  —  —  598,000  — 
Long-term debt 595,000  594,400  593,800  438,400  822,300 
Total debt 595,000  594,400  593,800  1,036,400  822,300 
Stockholders’ equity 4,574,300  4,148,300  3,140,400  2,956,200  2,619,000 
Total capital 5,169,300  4,742,700  3,734,200  3,992,600  3,441,300 
Solvency Ratio
Debt to capital1 0.12 0.13 0.16 0.26 0.24
Benchmarks
Debt to Capital, Competitors2
Becton, Dickinson & Co. 0.43 0.48 0.51 0.59 0.60
Boston Scientific Corp. 0.37 0.42 0.45 0.44 0.45
Danaher Corp. 0.35 0.42 0.26 0.29 0.35
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00
Medtronic PLC 0.33 0.34 0.34 0.40 0.38
Stryker Corp. 0.52 0.46 0.46 0.42 0.42
Thermo Fisher Scientific Inc. 0.39 0.37 0.41 0.45 0.44
UnitedHealth Group Inc. 0.40 0.41 0.41 0.40 0.46
Debt to Capital, Sector
Health Care Equipment & Services 0.37 0.39 0.38 0.41 0.41
Debt to Capital, Industry
Health Care 0.48 0.48 0.45 0.46 0.44

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Debt to capital = Total debt ÷ Total capital
= 595,000 ÷ 5,169,300 = 0.12

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio A solvency ratio calculated as total debt divided by total debt plus shareholders’ equity. Edwards Lifesciences Corp.’s debt to capital ratio improved from 2018 to 2019 and from 2019 to 2020.

Debt to Capital (including Operating Lease Liability)

Edwards Lifesciences Corp., debt to capital (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Short-term debt —  —  —  598,000  — 
Long-term debt 595,000  594,400  593,800  438,400  822,300 
Total debt 595,000  594,400  593,800  1,036,400  822,300 
Operating lease liabilities, current portion 27,200  25,500  —  —  — 
Operating lease liabilities, long-term portion 72,700  58,900  —  —  — 
Total debt (including operating lease liability) 694,900  678,800  593,800  1,036,400  822,300 
Stockholders’ equity 4,574,300  4,148,300  3,140,400  2,956,200  2,619,000 
Total capital (including operating lease liability) 5,269,200  4,827,100  3,734,200  3,992,600  3,441,300 
Solvency Ratio
Debt to capital (including operating lease liability)1 0.13 0.14 0.16 0.26 0.24
Benchmarks
Debt to Capital (including Operating Lease Liability), Competitors2
Becton, Dickinson & Co. 0.44 0.48 0.51 0.59 0.60
Boston Scientific Corp. 0.39 0.43 0.45 0.44 0.45
Danaher Corp. 0.36 0.43 0.26 0.29 0.35
Intuitive Surgical Inc. 0.01 0.01 0.00 0.00 0.00
Medtronic PLC 0.34 0.34 0.34 0.40 0.38
Stryker Corp. 0.52 0.47 0.46 0.42 0.42
Thermo Fisher Scientific Inc. 0.40 0.38 0.41 0.45 0.44
UnitedHealth Group Inc. 0.42 0.44 0.41 0.40 0.46
Debt to Capital (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.39 0.40 0.38 0.41 0.41
Debt to Capital (including Operating Lease Liability), Industry
Health Care 0.49 0.48 0.45 0.46 0.44

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= 694,900 ÷ 5,269,200 = 0.13

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to capital ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total debt (including operating lease liability) plus shareholders’ equity. Edwards Lifesciences Corp.’s debt to capital ratio (including operating lease liability) improved from 2018 to 2019 and from 2019 to 2020.

Debt to Assets

Edwards Lifesciences Corp., debt to assets calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Short-term debt —  —  —  598,000  — 
Long-term debt 595,000  594,400  593,800  438,400  822,300 
Total debt 595,000  594,400  593,800  1,036,400  822,300 
 
Total assets 7,237,100  6,488,100  5,323,700  5,695,800  4,510,000 
Solvency Ratio
Debt to assets1 0.08 0.09 0.11 0.18 0.18
Benchmarks
Debt to Assets, Competitors2
Becton, Dickinson & Co. 0.33 0.37 0.40 0.50 0.45
Boston Scientific Corp. 0.30 0.33 0.34 0.29 0.30
Danaher Corp. 0.28 0.35 0.20 0.23 0.27
Intuitive Surgical Inc. 0.00 0.00 0.00 0.00 0.00
Medtronic PLC 0.27 0.28 0.28 0.34 0.31
Stryker Corp. 0.41 0.37 0.36 0.33 0.34
Thermo Fisher Scientific Inc. 0.31 0.30 0.34 0.37 0.36
UnitedHealth Group Inc. 0.22 0.23 0.24 0.23 0.27
Debt to Assets, Sector
Health Care Equipment & Services 0.27 0.29 0.28 0.30 0.30
Debt to Assets, Industry
Health Care 0.33 0.33 0.31 0.32 0.31

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Debt to assets = Total debt ÷ Total assets
= 595,000 ÷ 7,237,100 = 0.08

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio A solvency ratio calculated as total debt divided by total assets. Edwards Lifesciences Corp.’s debt to assets ratio improved from 2018 to 2019 and from 2019 to 2020.

Debt to Assets (including Operating Lease Liability)

Edwards Lifesciences Corp., debt to assets (including operating lease liability) calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Short-term debt —  —  —  598,000  — 
Long-term debt 595,000  594,400  593,800  438,400  822,300 
Total debt 595,000  594,400  593,800  1,036,400  822,300 
Operating lease liabilities, current portion 27,200  25,500  —  —  — 
Operating lease liabilities, long-term portion 72,700  58,900  —  —  — 
Total debt (including operating lease liability) 694,900  678,800  593,800  1,036,400  822,300 
 
Total assets 7,237,100  6,488,100  5,323,700  5,695,800  4,510,000 
Solvency Ratio
Debt to assets (including operating lease liability)1 0.10 0.10 0.11 0.18 0.18
Benchmarks
Debt to Assets (including Operating Lease Liability), Competitors2
Becton, Dickinson & Co. 0.34 0.37 0.40 0.50 0.45
Boston Scientific Corp. 0.31 0.34 0.34 0.29 0.30
Danaher Corp. 0.29 0.36 0.20 0.23 0.27
Intuitive Surgical Inc. 0.01 0.01 0.00 0.00 0.00
Medtronic PLC 0.28 0.28 0.28 0.34 0.31
Stryker Corp. 0.42 0.38 0.36 0.33 0.34
Thermo Fisher Scientific Inc. 0.33 0.32 0.34 0.37 0.36
UnitedHealth Group Inc. 0.24 0.26 0.24 0.23 0.27
Debt to Assets (including Operating Lease Liability), Sector
Health Care Equipment & Services 0.28 0.30 0.28 0.30 0.30
Debt to Assets (including Operating Lease Liability), Industry
Health Care 0.34 0.34 0.31 0.32 0.31

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= 694,900 ÷ 7,237,100 = 0.10

2 Click competitor name to see calculations.

Solvency ratio Description The company
Debt to assets ratio (including operating lease liability) A solvency ratio calculated as total debt (including operating lease liability) divided by total assets. Edwards Lifesciences Corp.’s debt to assets ratio (including operating lease liability) improved from 2018 to 2019 and from 2019 to 2020.

Financial Leverage

Edwards Lifesciences Corp., financial leverage calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Total assets 7,237,100  6,488,100  5,323,700  5,695,800  4,510,000 
Stockholders’ equity 4,574,300  4,148,300  3,140,400  2,956,200  2,619,000 
Solvency Ratio
Financial leverage1 1.58 1.56 1.70 1.93 1.72
Benchmarks
Financial Leverage, Competitors2
Becton, Dickinson & Co. 2.27 2.46 2.57 2.91 3.35
Boston Scientific Corp. 2.01 2.20 2.41 2.72 2.69
Danaher Corp. 1.92 2.05 1.70 1.77 1.97
Intuitive Surgical Inc. 1.15 1.18 1.17 1.22 1.12
Medtronic PLC 1.79 1.79 1.80 1.98 1.92
Stryker Corp. 2.62 2.36 2.32 2.23 2.14
Thermo Fisher Scientific Inc. 2.00 1.97 2.04 2.23 2.13
UnitedHealth Group Inc. 3.01 3.02 2.94 2.91 3.21
Financial Leverage, Sector
Health Care Equipment & Services 2.22 2.25 2.21 2.31 2.33
Financial Leverage, Industry
Health Care 2.82 2.77 2.68 2.66 2.54

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Financial leverage = Total assets ÷ Stockholders’ equity
= 7,237,100 ÷ 4,574,300 = 1.58

2 Click competitor name to see calculations.

Solvency ratio Description The company
Financial leverage ratio A solvency ratio calculated as total assets divided by total shareholders’ equity. Edwards Lifesciences Corp.’s financial leverage ratio decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.

Interest Coverage

Edwards Lifesciences Corp., interest coverage calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Net income 823,400  1,046,900  722,200  583,600  569,500 
Add: Income tax expense 93,300  119,600  39,200  451,300  168,400 
Add: Interest expense 15,800  20,700  29,900  23,200  19,200 
Earnings before interest and tax (EBIT) 932,500  1,187,200  791,300  1,058,100  757,100 
Solvency Ratio
Interest coverage1 59.02 57.35 26.46 45.61 39.43
Benchmarks
Interest Coverage, Competitors2
Becton, Dickinson & Co. 2.87 2.84 2.66 2.87 3.77
Boston Scientific Corp. 0.78 2.45 6.90 5.07 1.76
Danaher Corp. 17.35 31.44 21.92 19.06 15.16
Intuitive Surgical Inc.
Medtronic PLC 4.71 4.60 5.95 5.21 4.13
Stryker Corp. 7.20 9.93 9.92 9.35 9.43
Thermo Fisher Scientific Inc. 14.07 7.02 5.89 5.10 5.31
UnitedHealth Group Inc. 13.47 11.55 12.39 12.82 12.12
Interest Coverage, Sector
Health Care Equipment & Services 9.64 8.03 8.63 8.42 7.47
Interest Coverage, Industry
Health Care 7.98 9.95 9.71 10.14 10.74

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Interest coverage = EBIT ÷ Interest expense
= 932,500 ÷ 15,800 = 59.02

2 Click competitor name to see calculations.

Solvency ratio Description The company
Interest coverage ratio A solvency ratio calculated as EBIT divided by interest payments. Edwards Lifesciences Corp.’s interest coverage ratio improved from 2018 to 2019 and from 2019 to 2020.

Fixed Charge Coverage

Edwards Lifesciences Corp., fixed charge coverage calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Net income 823,400  1,046,900  722,200  583,600  569,500 
Add: Income tax expense 93,300  119,600  39,200  451,300  168,400 
Add: Interest expense 15,800  20,700  29,900  23,200  19,200 
Earnings before interest and tax (EBIT) 932,500  1,187,200  791,300  1,058,100  757,100 
Add: Operating lease costs 30,500  27,900  27,000  27,300  22,900 
Earnings before fixed charges and tax 963,000  1,215,100  818,300  1,085,400  780,000 
 
Interest expense 15,800  20,700  29,900  23,200  19,200 
Operating lease costs 30,500  27,900  27,000  27,300  22,900 
Fixed charges 46,300  48,600  56,900  50,500  42,100 
Solvency Ratio
Fixed charge coverage1 20.80 25.00 14.38 21.49 18.53
Benchmarks
Fixed Charge Coverage, Competitors2
Becton, Dickinson & Co. 2.07 1.99 1.92 2.18 3.15
Boston Scientific Corp. 0.76 2.24 5.27 3.94 1.57
Danaher Corp. 7.10 8.38 8.49 8.14 7.46
Intuitive Surgical Inc. 58.48 79.65
Medtronic PLC 3.98 3.97 4.87 4.32 3.62
Stryker Corp. 5.39 7.10 6.86 6.55 6.65
Thermo Fisher Scientific Inc. 10.30 5.60 4.72 4.07 4.11
UnitedHealth Group Inc. 8.51 7.65 8.41 8.40 8.08
Fixed Charge Coverage, Sector
Health Care Equipment & Services 6.55 5.78 6.16 6.05 5.61
Fixed Charge Coverage, Industry
Health Care 6.14 7.68 7.66 7.99 8.46

Based on: 10-K (filing date: 2021-02-12), 10-K (filing date: 2020-02-14), 10-K (filing date: 2019-02-15), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).

1 2020 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 963,000 ÷ 46,300 = 20.80

2 Click competitor name to see calculations.

Solvency ratio Description The company
Fixed charge coverage ratio A solvency ratio calculated as earnings before fixed charges and tax divided by fixed charges. Edwards Lifesciences Corp.’s fixed charge coverage ratio improved from 2018 to 2019 but then slightly deteriorated from 2019 to 2020.